Evidence map›Paper›PMID 38899150›Full record

ArticleRSC pharmaceutics2024

Insight into the liposomal encapsulation of mono and bis-naphthalimides.

Abdullahi Magaji Dauda, Thomas Swift, Richard Telford, Hend A A Abd El-Wahab, Chhanda Charan Danta, Klaus Pors, Amalia Ruiz

Abstract read
In one paragraph

Article in RSC pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdullahi Magaji DaudaInstitute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford Bradford UK g.ruizestrada@bradford.ac.uk.
Thomas SwiftSchool of Chemistry and Biosciences, Faculty of Life Sciences, University of Bradford Bradford UK.ORCID https://orcid.org/0000-0002-8616-8458
Richard TelfordSchool of Chemistry and Biosciences, Faculty of Life Sciences, University of Bradford Bradford UK.
Hend A A Abd El-WahabInstitute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford Bradford UK g.ruizestrada@bradford.ac.uk.ORCID https://orcid.org/0000-0002-9008-6439
Chhanda Charan DantaInstitute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford Bradford UK g.ruizestrada@bradford.ac.uk.ORCID https://orcid.org/0000-0002-1436-9461
Klaus PorsInstitute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford Bradford UK g.ruizestrada@bradford.ac.uk.ORCID https://orcid.org/0000-0002-0837-5208
Amalia RuizInstitute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford Bradford UK g.ruizestrada@bradford.ac.uk.ORCID https://orcid.org/0000-0001-8358-5304

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitonafide-loaded liposomes are a promising strategy to overcome the neurotoxicity observed in clinical trials for this drug. This study investigates the influence of loaded mitonafide or a dimer analogue on different liposomal formulations and their therapeutic efficacy

Identifiers

PMID38899150
PMCPMC11185046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.